KPP
MRK icon

Kings Path Partners’s Merck MRK Stock Holding History

Kings Path Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Buy
2,608
+8
+0.3% +$936 0.09% 90
2026
Q1 		$274K Hold
2,600
– – 0.1% 91
2025
Q4 		$274K Hold
2,600
– – 0.1% 91
2025
Q3 		$218K Hold
2,600
– – 0.08% 98
2025
Q2 		$206K Hold
2,600
– – 0.08% 95
2025
Q1 		$233K Hold
2,600
– – 0.11% 92
2024
Q4 		$259K Sell
2,600
-25
-1% -$2.58K 0.11% 116
2024
Q3 		$298K Hold
2,625
– – 0.13% 111
2024
Q2 		$325K Buy
+2,625
New +$338K 0.15% 104

Other funds holding MRK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

Kings Path Partners's MRK Position: Q2 2026 in Review

Kings Path Partners increased its Merck (MRK) stake by 0.31% in Q2 2026, buying an estimated $936 and bringing the position to 2,608 shares worth $335K. The position accounts for 0.09% of the portfolio, ranked #90.

Kings Path Partners first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. 872 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Kings Path Partners held 2,608 shares of Merck worth $335K as of Q2 2026.
  • Kings Path Partners bought 8 Merck shares in Q2 2026, an estimated $936.
  • Merck made up 0.09% of Kings Path Partners's portfolio in Q2 2026, its #90 holding.
  • Kings Path Partners first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
  • 872 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.